0001493152-24-011574.txt : 20240327 0001493152-24-011574.hdr.sgml : 20240327 20240327175343 ACCESSION NUMBER: 0001493152-24-011574 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240326 FILED AS OF DATE: 20240327 DATE AS OF CHANGE: 20240327 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yanez Michelle CENTRAL INDEX KEY: 0001958023 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41765 FILM NUMBER: 24792394 MAIL ADDRESS: STREET 1: 449 S. 12TH STREET UNIT 1705 CITY: TAMPA STATE: FL ZIP: 33602 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MIRA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001904286 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 853354547 STATE OF INCORPORATION: FL BUSINESS ADDRESS: STREET 1: 1200 BRICKELL AVENUE STREET 2: SUITE 1950 #1183 CITY: MIAMI STATE: FL ZIP: 33131 BUSINESS PHONE: 813-369-5150 MAIL ADDRESS: STREET 1: 324 SOUTH HYDE PARK AVENUE, SUITE 350 CITY: TAMPA STATE: FL ZIP: 33606 FORMER COMPANY: FORMER CONFORMED NAME: Mira1a Therapeutics, Inc. DATE OF NAME CHANGE: 20220112 4 1 ownership.xml X0508 4 2024-03-26 0 0001904286 MIRA PHARMACEUTICALS, INC. MIRA 0001958023 Yanez Michelle C/O MIRA PHARMACEUTICALS, INC. 1200 BRICKELL AVENUE, SUITE 1950 #1183 MIAMI FL 33131 0 1 0 0 Chief Financial Officer 0 Incentive Stock Option (right to buy) 1.15 2024-03-26 4 A 0 150000 0 A 2034-03-26 Common Stock 150000 57799 D The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on March 26, 2024. The options were granted under the Issuer's 2022 Amended and Restated Omnibus Incentive Plan (the "Plan") whereby 50% of such incentive options, or 75,000 options, will vest on the six month anniversary of the of the grant, or September 26, 2024, and the remaining 50% will vest on the first anniversary of the grant date, March 26, 2025. Represents (i) 3,334 stock options that were issued to the Reporting Person under the Plan that became exercisable on June 15, 2022 at an exercise price of $5.00 (ii) 3,333 stock options that were issued to the Reporting Person under the Plan that became exercise on June 15, 2023 at an exercise price of $5.00 each, (iii) 15,566 stock options were issued to the Reporting Person on April 28, 2023, pursuant to a grant under the Issuer's Plan which vested in full on April 28, 2024 at an exercise price of $6.50 each, (iv) 15,566 stock options were issued to the Reporting Person on April 28, 2023, pursuant to a grant under the Issuer's Plan which will vest in full on April 28, 2024 at an exercise price of $6.50 each (v) 20,000 stock options were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which vested in full on August 17, 2023 at an exercise price of $6.50 each. /s/ Michelle Yanez 2024-03-27